{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T21:30:31Z","timestamp":1781818231900,"version":"3.54.5"},"reference-count":28,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DDDT"],"DOI":"10.2147\/dddt.s501111","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T09:10:13Z","timestamp":1750324213000},"page":"5271-5282","source":"Crossref","is-referenced-by-count":6,"title":["Pharmacokinetics, Pharmacodynamic, Safety and Tolerability of Fazamorexant, a Novel Dual Orexin Receptor Antagonist: Report of the First-in-Human Study"],"prefix":"10.2147","volume":"Volume 19","author":[{"given":"Jun","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoshun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,6]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"Itc33","DOI":"10.7326\/AITC202103160","volume":"174","author":"Sutton","year":"2021","journal-title":"Ann Internal Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11920-022-01326-3","volume":"24","author":"Mirchandaney","year":"2022","journal-title":"Curr Psychiatry Rep"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/clc.23984","volume":"46","author":"Dean","year":"2023","journal-title":"Clin Cardiology"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1001\/jama.2013.193","volume":"309","author":"Buysse","year":"2013","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"735","DOI":"10.2165\/11312920-000000000-00000","volume":"32","author":"Zammit","year":"2009","journal-title":"Drug Safety"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3109\/01677063.2011.566953","volume":"25","author":"Winrow","year":"2011","journal-title":"J Neurogen"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.12182\/20230260302","volume":"54","author":"Zheng","year":"2023","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1517\/13543784.2010.482926","volume":"19","author":"Hardeland","year":"2010","journal-title":"Expert Opin Invest Drugs"},{"key":"ref9","first-page":"1017","volume":"73","author":"Uchiyama","year":"2015","journal-title":"Nihon Rinsho Japan J Clin Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.encep.2019.01.006","volume":"46","author":"Dupuis","year":"2020","journal-title":"L\u2019Encephale"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1358\/dot.2009.45.4.1358835","volume":"45","author":"Owen","year":"2009","journal-title":"Drugs Today"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2147\/NSS.S76910","volume":"8","author":"Norman","year":"2016","journal-title":"Nat Sci Sleep"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s12264-019-00447-9","volume":"36","author":"Han","year":"2020","journal-title":"Neurosci Bulletin"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1016\/j.bmcl.2015.05.012","volume":"25","author":"Boss","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fnins.2014.00028","volume":"8","author":"Dugovic","year":"2014","journal-title":"Front Neurosci"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"6518","DOI":"10.1523\/JNEUROSCI.6506-10.2011","volume":"31","author":"Mieda","year":"2011","journal-title":"J Neurosci"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature06310","volume":"450","author":"Adamantidis","year":"2007","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s11920-022-01357-w","volume":"24","author":"Wu","year":"2022","journal-title":"Curr Psychiatry Rep"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1146\/annurev-pharmtox-010716-104837","volume":"57","author":"Coleman","year":"2017","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s40265-020-01276-1","volume":"80","author":"Scott","year":"2020","journal-title":"Drugs"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s40265-022-01699-y","volume":"82","author":"Markham","year":"2022","journal-title":"Drugs"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"259","DOI":"10.5665\/sleep.2386","volume":"36","author":"Sun","year":"2013","journal-title":"Sleep"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"101573","DOI":"10.1016\/j.smrv.2021.101573","volume":"61","author":"Xue","year":"2022","journal-title":"Sleep Med Rev"},{"key":"ref24","unstructured":"BELSOMRA\u00ae (suvorexant) tablets [prescribing information]. U.S.; August, 2014."},{"key":"ref25","unstructured":"DAYVIGOTM\u00ae (lemborexant) tablets [prescribing information]. U.S.; December, 2019."},{"key":"ref26","unstructured":"QUVIVIQ\u00ae (daridorexant) tablets [prescribing information]. U.S.; January, 2022."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.pharma.2023.05.004","volume":"81","author":"Rajbhar","year":"2023","journal-title":"Ann Pharm Fr"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"119009","DOI":"10.1016\/j.ijpharm.2019.119009","volume":"577","author":"Siepmann","year":"2020","journal-title":"Int J Pharm"}],"container-title":["Drug Design, Development and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/104059","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/104059","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T09:10:16Z","timestamp":1750324216000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/pharmacokinetics-pharmacodynamic-safety-and-tolerability-of-fazamorexa-peer-reviewed-fulltext-article-DDDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":28,"URL":"https:\/\/doi.org\/10.2147\/dddt.s501111","relation":{},"ISSN":["1177-8881"],"issn-type":[{"value":"1177-8881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]}}}